Training and Match Demands of Elite Rugby Union.

ABSTRACT: Cousins, BEW, Morris, JG, Sunderland, C, Bennett, AM, Shahtahmassebi, G, and Cooper, SB. Training and match demands of elite rugby union. J Strength Cond Res 37(1): 141-148, 2023-This study aimed to examine training and match demands associated with elite Rugby Union. Eighty-nine elite players were monitored using subjective (session ratings of perceived exertion) and objective (global positioning systems: distance and high-speed running [defined as >70% of individual maximum speed] distance) methods, alongside key performance indicator variables in matches (e.g., number of tackles made). These were compared between positions (forwards vs. backs) and league of competition (Premiership vs. Championship). Statistical significance was accepted as p < 0.05. Analysis revealed that backs covered greater distance (by 704 m, p < 0.001) in training and greater distance (by 7.6 m·min-1, p < 0.001) and high-speed running distance (by 1.22 m·min-1, p < 0.001) in matches, compared with forwards. In matches, the forwards experience greater key performance indicator demand (tackles: 78%; tackle assists: 207%; breakdown entries: 324%; contact events: 117%; all p < 0.001) compared with backs. The number of tackles (53%, p < 0.001) and tackles missed (35%, p = 0.001) were greater, whereas contact carries (12%, p = 0.010) and breakdown entries (10%, p = 0.024) were lower, in the Premiership compared with the Championship. Overall, these findings confirm that the running demands of Rugby Union are higher in backs, whereas contact actions are higher in forwards, with further differences between the Premiership and Championship. This comprehensive examination of the demands of elite Rugby Union could be used to ensure the specificity of training protocols for elite Rugby Union clubs, specific to both playing position (forward or back) and level of competition (Premiership or Championship).

Synthetic playing surfaces increase the incidence of match injuries in an elite Rugby Union team.

OBJECTIVES: To examine differences in match injury incidence between three playing surfaces in elite Rugby Union. DESIGN: Prospective cohort. METHODS: Match injury incidence was assessed in 89 elite Rugby Union players over two-seasons of professional competition (44 matches, 1014 h player exposure). Match injury incidence was assessed on three different playing surfaces; natural grass, hybrid (natural grass combined with approximately 3% synthetic fibres) and fully synthetic (sand and rubber infill). Overall injury incidence, contact and non-contact injury incidence, and the incidence of minor (≤7 d lost) and major (≥8 d lost) injuries were considered using mixed effect models. RESULTS: Overall match injury incidence doubled on hybrid and synthetic surfaces compared to natural grass (hybrid: OR = 2.58 [95% CI 1.65-4.03], p < 0.001; synthetic: OR = 2.16 [95% CI 1.07-4.37], p = 0.033). Furthermore, the odds of sustaining a contact injury on a pitch containing any synthetic content also increased compared to natural grass (hybrid: OR = 2.31 [95% CI 1.41-3.78], p = 0.001; synthetic: OR = 2.19 [95% CI 1.00-4.77], p = 0.049). The hybrid surface elicited a four times greater likelihood of non-contact injury incidence compared to natural grass (OR = 4.18 [95% CI 1.16-15.04], p = 0.028). However, the playing surface did not affect the severity of match injuries (all p > 0.05). CONCLUSIONS: The present study suggests that even a small percentage (3%) of synthetic content in the playing surface significantly increases match injury incidence, with an effect seen on both contact and non-contact injury incidence. These findings are important to enable practitioners to be aware of the injury implications of playing matches on hybrid and synthetic pitches.

Match and Training Load Exposure and Time-Loss Incidence in Elite Rugby Union Players.

OBJECTIVE: To investigate the impact of match and training load on time-loss incidence in elite, professional Rugby Union players. MATERIALS AND METHODS: Eighty-nine Rugby Union players were monitored over two seasons of training and competition. Load was measured for all training sessions and matches using subjective [session ratings of perceived exertion (sRPE) load; RPE × session duration] and objective [global positioning systems (GPS); distance and high-speed running distance] methods and quantified using multiple approaches; absolute match and training load, acute:chronic workload ratio (ACWR), exponentially weighted moving average (EWMA) and cumulative 7, 14, 21, and 28 d sums. Mixed effect models were used to assess the effect of each variable on time-loss incidence. RESULTS: Of the 474 time-loss incidences that occurred across the two seasons, 50.0% were contact injuries (86.5% occurred during matches and 13.5% during training), 34.8% were non-contact injuries (31.5% occurred during matches and 68.5% during training) and 15.2% were cases of illness. The absolute match and training load variables provided the best explanation of the variance in time-loss incidence occurrence [sRPE load: p < 0.001, Akaike information criterion (AIC) = 2936; distance: p < 0.001, AIC = 3004; high-speed running distance: p < 0.001, AIC = 3025]. The EWMA approach (EWMA sRPE load: p < 0.001, AIC = 2980; EWMA distance: p < 0.001, AIC = 2980; EWMA high-speed running distance: p = 0.002, AIC = 2987) also explained more of the variance in time-loss incidence occurrence than the ACWR approach (ACWR sRPE load: p = 0.091, AIC = 2993; ACWR distance: p = 0.008, AIC = 2990; ACWR high-speed running distance: p = 0.153, AIC = 2994). CONCLUSION: Overall, the absolute sRPE load variable best explained the variance in time-loss incidence, followed by absolute distance and absolute high-speed running distance. Whilst the model fit using the EWMA approach was not as good as the absolute load variables, it was better than when the same variables were calculated using the ACWR method. Overall, these findings suggest that the absolute match and training load variables provide the best predictors of time-loss incidence rates, with sRPE load likely to be the optimal variant of those examined here.

Cell-free protein synthesis of a cytotoxic cancer therapeutic: Onconase production and a just-add-water cell-free system.

Biotherapeutics have many promising applications, such as anti-cancer treatments, immune suppression, and vaccines. However, due to their biological nature, some biotherapeutics can be challenging to rapidly express and screen for activity through traditional recombinant methods. For example, difficult-to-express proteins may be cytotoxic or form inclusion bodies during expression, increasing the time, labor, and difficulty of purification and downstream characterization. One potential pathway to simplify the expression and screening of such therapeutics is to utilize cell-free protein synthesis. Cell-free systems offer a compelling alternative to in vivo production, due to their open and malleable reaction environments. In this work, we demonstrate the use of cell-free systems for the expression and direct screening of the difficult-to-express cytotoxic protein onconase. Using cell-free systems, onconase can be rapidly expressed in soluble, active form. Furthermore, the open nature of the reaction environment allows for direct and immediate downstream characterization without the need of purification. Also, we report the ability of a "just-add-water" lyophilized cell-fee system to produce onconase. This lyophilized system remains viable after being stored above freezing for up to one year. The beneficial features of these cell-free systems make them compelling candidates for future biotherapeutic screening and production.

Creating a completely "cell-free" system for protein synthesis.

Cell-free protein synthesis is a promising tool to take biotechnology outside of the cell. A cell-free approach provides distinct advantages over in vivo systems including open access to the reaction environment and direct control over all chemical components for facile optimization and synthetic biology integration. Promising applications of cell-free systems include portable diagnostics, biotherapeutics expression, rational protein engineering, and biocatalyst production. The highest yielding and most economical cell-free systems use an extract composed of the soluble component of lysed Escherichia coli. Although E. coli lysis can be highly efficient (>99.999%), one persistent challenge is that the extract remains contaminated with up to millions of cells per mL. In this work, we examine the potential of multiple decontamination strategies to further reduce or eliminate bacteria in cell-free systems. Two strategies, sterile filtration and lyophilization, effectively eliminate contaminating cells while maintaining the systems' protein synthesis capabilities. Lyophilization provides the additional benefit of long-term stability at storage above freezing. Technologies for personalized, portable medicine and diagnostics can be expanded based on these foundational sterilized and completely "cell-free" systems.

The emerging age of cell-free synthetic biology.

The engineering of and mastery over biological parts has catalyzed the emergence of synthetic biology. This field has grown exponentially in the past decade. As increasingly more applications of synthetic biology are pursued, more challenges are encountered, such as delivering genetic material into cells and optimizing genetic circuits in vivo. An in vitro or cell-free approach to synthetic biology simplifies and avoids many of the pitfalls of in vivo synthetic biology. In this review, we describe some of the innate features that make cell-free systems compelling platforms for synthetic biology and discuss emerging improvements of cell-free technologies. We also select and highlight recent and emerging applications of cell-free synthetic biology.

Foot-and-mouth disease: technical and political challenges to eradication.

Foot-and-mouth disease (FMD) is a highly-contagious livestock disease with global socioeconomic ramifications. The disease negatively impacts both individual farmers through reduced herd viability and nations through trade restrictions of animals and animal derivatives. Vaccines for FMD prevention have existed for over 70 years, yet the disease remains enzootic in a large percentage of the globe. FMD persistence is due in part to technical limitations of historic and current vaccine technologies. There also exist many socioeconomic and political barriers to global FMD eradication. Here we highlight the barriers to eradication and discuss potential avenues toward FMD eradication.